Form 8-K - Current report:
SEC Accession No. 0000950170-25-104015
Filing Date
2025-08-06
Accepted
2025-08-06 16:10:28
Documents
11
Period of Report
2025-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imnm-20250806.htm   iXBRL 8-K 54201
2 EX-99.1 imnm-ex99_1.htm EX-99.1 131078
  Complete submission text file 0000950170-25-104015.txt   362796

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT imnm-20250806.xsd EX-101.SCH 61492
13 EXTRACTED XBRL INSTANCE DOCUMENT imnm-20250806_htm.xml XML 4706
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 251189639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)